These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9816301)

  • 1. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells.
    Frankel A; Mills GB
    Clin Cancer Res; 1996 Aug; 2(8):1307-13. PubMed ID: 9816301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
    Furui T; LaPushin R; Mao M; Khan H; Watt SR; Watt MA; Lu Y; Fang X; Tsutsui S; Siddik ZH; Bast RC; Mills GB
    Clin Cancer Res; 1999 Dec; 5(12):4308-18. PubMed ID: 10632375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cytostatic agents on the expression of epidermal growth factor receptor in ovarian cancer cells.
    Lang T; Daxenbichler G; Marth C
    Anticancer Res; 1994; 14(5A):1871-4. PubMed ID: 7847819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells.
    Dodier P; Piché A
    Gynecol Oncol; 2006 Feb; 100(2):254-63. PubMed ID: 16188300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of follicle stimulating hormone on apoptosis of human epithelial ovarian cancer cell induced by cisplatin].
    Huang CF; Liu DY; Xu WH; Shen K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):443-6. PubMed ID: 12974092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mifepristone on the proliferation, apoptosis and cis-diamminedichloroplatinum sensitivity of cultured chemoresistant human ovarian cancer cells.
    Wang G; Shang HL; Xie Y; Xiao P; Li XJ; Lin TC; Li GY
    Chin Med J (Engl); 2005 Feb; 118(4):333-6. PubMed ID: 15740674
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model.
    Chan JK; Pham H; You XJ; Cloven NG; Burger RA; Rose GS; Van Nostrand K; Korc M; Disaia PJ; Fan H
    Cancer Res; 2005 Apr; 65(8):3243-8. PubMed ID: 15833856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alphavbeta 6 integrin inhibits cisplatin-induced apoptosis in ovarian cancer cell lines].
    Wu XH; Li DX; Li L; Guo YH; Yang B; Shan BE
    Zhonghua Fu Chan Ke Za Zhi; 2004 Feb; 39(2):112-5. PubMed ID: 15059590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
    Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
    Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patterns of cisplatin induced apoptosis in ovarian cancer cell line COC1].
    Lu Y; Wang S; Qi X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):160-2. PubMed ID: 10682485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
    Li D; Williams JI; Pietras RJ
    Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.
    Ji C; Cao C; Lu S; Kivlin R; Amaral A; Kouttab N; Yang H; Chu W; Bi Z; Di W; Wan Y
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):857-65. PubMed ID: 18214481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.
    Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Kouttab N; Chu W; Wan Y
    Int J Oncol; 2006 Oct; 29(4):1003-11. PubMed ID: 16964397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
    Xu Y; Gaudette DC; Boynton JD; Frankel A; Fang XJ; Sharma A; Hurteau J; Casey G; Goodbody A; Mellors A
    Clin Cancer Res; 1995 Oct; 1(10):1223-32. PubMed ID: 9815916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAG-1 p29 protein prevents drug-induced cell death in the presence of EGF and enhances resistance to anoikis in SKOV3 human ovarian cancer cells.
    Pagé V; Côté M; Rancourt C; Sullivan M; Piché A
    Biochem Biophys Res Commun; 2005 Mar; 328(4):874-84. PubMed ID: 15707960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.